ICMR partners with Bharat Biotech to develop Covid-19 vaccine
Follow The Hawk on Google News+ FollowAdvertisement

New Delhi: The Indian Council of Medical Research (ICMR) on Saturday partnered with Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for coronavirus.
According to a statement issued by the ICMR, the team will use the virus strain isolated at ICMR''s National Institute of Virology (NIV) in Pune.
Advertisement
"The strain has been successfully transferred from NIV to Bharat Biotech International Ltd (BBIL). Work on vaccine development has been initiated between the two partners. ICMR-NIV will provide continuous support to BBIL for vaccine development. ICMR and BBIL will seek fast-track approvals to expedite vaccine development, subsequent animal studies and clinical evaluation of the candidate vaccine," read the statement.
Also readFSSAI to initiate action against Bisleri over unsafe water sample
According to the Union Health Ministry data, India has so far reported 59,662 Covid-19 cases of which 17,847 persons have been cured while 1,981 people have succumbed to the dreaded virus.
--IANS
Get The Hawk first on Google
Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.
Advertisement








